Prediction of extraprostatic cancer by serum [-2] pro prostate specific antigen in clinically localized prostate cancer

被引：0
|
作者：
Nakashima, Jun
Yamazaki, Keiichi
Kikuchi, Eiji
Miyajima, Akira
Nakagawa, Ken
Oya, Mototsugu
Ohigashi, Takashi
Murai, Masaru
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)31367-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
  • [41] Prostate specific antigen variation in patients without clinically evident prostate cancer
    Lujan, M
    Paez, A
    Sanchez, E
    Herrero, A
    Martin, E
    Berenguer, A
    JOURNAL OF UROLOGY, 1999, 162 (04): : 1311 - 1313
  • [42] The use of prostate specific antigen density to predict clinically significant prostate cancer
    Igor Yusim
    Muhammad Krenawi
    Elad Mazor
    Victor Novack
    Nicola J. Mabjeesh
    Scientific Reports, 10
  • [43] The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer
    Partin, AW
    Carter, HB
    UROLOGIC CLINICS OF NORTH AMERICA, 1996, 23 (04) : 531 - +
  • [44] Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?
    T Imamoto
    H Suzuki
    M Yano
    K Kawamura
    N Kamiya
    K Araki
    A Komiya
    Y Naya
    T Shiraishi
    T Ichikawa
    Prostate Cancer and Prostatic Diseases, 2009, 12 : 78 - 82
  • [45] Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?
    Imamoto, T.
    Suzuki, H.
    Yano, M.
    Kawamura, K.
    Kamiya, N.
    Araki, K.
    Komiya, A.
    Naya, Y.
    Shiraishi, T.
    Ichikawa, T.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2009, 12 (01) : 78 - 82
  • [46] Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era
    D'Amico, AV
    Moul, J
    Carroll, PR
    Sun, L
    Lubeck, D
    Chen, MH
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (11) : 2163 - 2172
  • [47] Observation for Clinically Localized Prostate Cancer
    Nelson, Joel B.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (13) : 1295 - 1298
  • [48] Biochemical and clinical outcomes after radical prostatectomy for clinically localized prostate cancer during the prostate specific antigen era
    Quek, ML
    Daneshmand, S
    Skinner, EC
    Vaishnav, A
    Cai, J
    Stein, JP
    Skinner, DG
    Lieskovsky, G
    JOURNAL OF UROLOGY, 2004, 171 (04): : 210 - 210
  • [49] Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancer
    Ingenito, AC
    Ennis, RD
    Hsu, IC
    Begg, MD
    Benson, MC
    Schiff, PB
    UROLOGY, 1997, 50 (01) : 73 - 78
  • [50] Hypofractionation for clinically localized prostate cancer
    Hickey, Brigid E.
    James, Melissa L.
    Daly, Tiffany
    Soh, Feng-Yi
    Jeffery, Mark
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (09):
12345